JP2004175807A5 - - Google Patents

Download PDF

Info

Publication number
JP2004175807A5
JP2004175807A5 JP2004027473A JP2004027473A JP2004175807A5 JP 2004175807 A5 JP2004175807 A5 JP 2004175807A5 JP 2004027473 A JP2004027473 A JP 2004027473A JP 2004027473 A JP2004027473 A JP 2004027473A JP 2004175807 A5 JP2004175807 A5 JP 2004175807A5
Authority
JP
Japan
Prior art keywords
optionally substituted
formula
ring
pharmaceutically acceptable
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004027473A
Other languages
English (en)
Japanese (ja)
Other versions
JP4367762B2 (ja
JP2004175807A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2004027473A priority Critical patent/JP4367762B2/ja
Priority claimed from JP2004027473A external-priority patent/JP4367762B2/ja
Publication of JP2004175807A publication Critical patent/JP2004175807A/ja
Publication of JP2004175807A5 publication Critical patent/JP2004175807A5/ja
Application granted granted Critical
Publication of JP4367762B2 publication Critical patent/JP4367762B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004027473A 2001-03-01 2004-02-04 Hivインテグラーゼ阻害活性を有する含窒素芳香族複素環化合物 Expired - Fee Related JP4367762B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2004027473A JP4367762B2 (ja) 2001-03-01 2004-02-04 Hivインテグラーゼ阻害活性を有する含窒素芳香族複素環化合物

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2001057037 2001-03-01
JP2001243530 2001-08-10
JP2001395022 2001-12-26
JP2004027473A JP4367762B2 (ja) 2001-03-01 2004-02-04 Hivインテグラーゼ阻害活性を有する含窒素芳香族複素環化合物

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2002569806A Division JP3616628B2 (ja) 2001-03-01 2002-02-27 Hivインテグラーゼ阻害活性を有する含窒素芳香族複素環化合物

Publications (3)

Publication Number Publication Date
JP2004175807A JP2004175807A (ja) 2004-06-24
JP2004175807A5 true JP2004175807A5 (enExample) 2005-06-23
JP4367762B2 JP4367762B2 (ja) 2009-11-18

Family

ID=27346141

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2002569806A Expired - Fee Related JP3616628B2 (ja) 2001-03-01 2002-02-27 Hivインテグラーゼ阻害活性を有する含窒素芳香族複素環化合物
JP2004027473A Expired - Fee Related JP4367762B2 (ja) 2001-03-01 2004-02-04 Hivインテグラーゼ阻害活性を有する含窒素芳香族複素環化合物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2002569806A Expired - Fee Related JP3616628B2 (ja) 2001-03-01 2002-02-27 Hivインテグラーゼ阻害活性を有する含窒素芳香族複素環化合物

Country Status (16)

Country Link
US (2) US7148237B2 (enExample)
EP (2) EP2033952B1 (enExample)
JP (2) JP3616628B2 (enExample)
KR (1) KR20030078958A (enExample)
CN (1) CN1659143A (enExample)
AT (1) ATE411292T1 (enExample)
BR (1) BR0207809A (enExample)
CA (1) CA2439666A1 (enExample)
CZ (1) CZ20032332A3 (enExample)
DE (1) DE60229364D1 (enExample)
HU (1) HUP0400175A2 (enExample)
IL (1) IL157638A0 (enExample)
MX (1) MXPA03007765A (enExample)
NO (1) NO20033848L (enExample)
PL (1) PL365027A1 (enExample)
WO (1) WO2002070486A1 (enExample)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ511255A (en) * 2001-04-20 2003-12-19 Deep Video Imaging Ltd Multi-focal plane display having an optical retarder and a diffuser interposed between its screens
DE10178132T1 (de) 2001-08-10 2016-06-23 Shionogi & Co., Ltd. Antivirales Mittel
DE10145457A1 (de) * 2001-09-14 2003-04-03 Basf Ag Substituierte Imidazo[1,2-a]-5,6,7,8-tetrahydropyridin-8-one, Verfahren zu ihrer Herstellung, sowie deren Verwendung zur Herstellung von Imidazo[1,2,-a]pyridinen
SI1441734T1 (sl) * 2001-10-26 2007-08-31 Angeletti P Ist Richerche Bio Dihidropirimidin karboksamidni inhibitorji HIV-integraze
DE122008000016I1 (de) * 2001-10-26 2011-12-01 Angeletti P Ist Richerche Bio N-substituierte hydroxypyrimidinoncarboxamidhemmerder HIV-integrase.
CA2478310A1 (en) * 2002-03-15 2003-09-25 Merck & Co., Inc. N-(substituted benzyl)-8-hydroxy-1,6-naphthyridine-7-carboxamides useful as hiv integrase inhibitors
US7358249B2 (en) * 2002-08-13 2008-04-15 Shionogi & Co., Ltd. Heterocyclic compounds having inhibitory activity against HIV integrase
PA8586801A1 (es) 2002-10-31 2005-02-04 Pfizer Inhibidores de hiv-integrasa, composiciones farmaceuticas y metodos para su uso
KR100665919B1 (ko) 2002-11-20 2007-03-08 니뽄 다바코 산교 가부시키가이샤 4-옥소퀴놀린 화합물 및 hiv 인테그라제 저해제로서의그의 용도
EP1590349A1 (en) 2003-01-27 2005-11-02 Pfizer Inc. Hiv-integrase inhibitors, pharmaceutical compositions, and methods for their use
US7812016B2 (en) * 2003-05-13 2010-10-12 Smithkline Beecham Corporation Naphthyridine integrase inhibitors
CN1318424C (zh) * 2003-06-18 2007-05-30 复旦大学 芳杂环羧酸衍生物,制备方法及在药学上的应用
ES2433477T3 (es) 2004-02-11 2013-12-11 Glaxosmithkline Llc Inhibidores de integrasa de VIH
WO2005087768A1 (en) * 2004-03-09 2005-09-22 Merck & Co., Inc. Hiv integrase inhibitors
BRPI0510319A (pt) * 2004-04-26 2007-10-16 Pfizer inibidores da enzima integrase de hiv
JP2007534738A (ja) 2004-04-26 2007-11-29 ファイザー・インク Hivインテグラーゼ酵素の阻害剤
WO2005113509A1 (en) * 2004-05-20 2005-12-01 Japan Tobacco Inc. Novel 4-oxoquinoline compound and use thereof as hiv integrase inhibitor
MY134672A (en) * 2004-05-20 2007-12-31 Japan Tobacco Inc Stable crystal of 4-oxoquinoline compound
EP2229945A1 (en) 2004-05-21 2010-09-22 Japan Tobacco, Inc. Combinations comprising a 4-isoquinolone derivative and anti-HIV agents
WO2005121132A1 (ja) * 2004-06-11 2005-12-22 Shionogi & Co., Ltd. 抗hcv作用を有する縮合ヘテロ環化合物
SG156636A1 (en) 2004-10-12 2009-11-26 Decode Genetics Ehf Carboxylic acid peri -substituted bicyclics for occlusive artery disease
US7674822B2 (en) 2004-11-24 2010-03-09 Wyeth PTP1b inhibitors
JP2008542352A (ja) * 2005-06-01 2008-11-27 ビオアリアンス ファルマ キノリン化合物及び他のhiv感染治療薬を含む相乗作用のコンビネーション
PT1928457E (pt) * 2005-09-30 2013-02-19 Pulmagen Therapeutics Asthma Ltd Quinolinas e sua utilização terapêutica
US7939537B2 (en) * 2005-10-04 2011-05-10 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. HIV integrase inhibitors
WO2007089030A1 (en) * 2006-02-01 2007-08-09 Japan Tobacco Inc. Use of 6-(3-chloro-2-fluorobenzyl)-1-[(2s)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid or salt thereof for treating retrovirus infection
EP2295432A1 (en) 2006-02-10 2011-03-16 TransTech Pharma Inc. Process for the preparation of aminobenzimidazole derivatives
RS54047B1 (sr) 2006-03-06 2015-10-30 Japan Tobacco Inc. Postupak za dobijanje jedinjenja 4-oksohinolina
ES2487967T3 (es) * 2006-04-20 2014-08-25 Pfizer Products Inc. Compuestos amido heterocíclicos condensados con fenilo para la prevención y el tratamiento de enfermedades mediadas por la glucoquinasa
EP2079699A1 (en) * 2006-07-25 2009-07-22 Envivo Pharmaceuticals, Inc. Quinoline derivatives
EP2091948B1 (en) * 2006-11-30 2012-04-18 Probiodrug AG Novel inhibitors of glutaminyl cyclase
EP2173354A4 (en) * 2007-08-09 2011-10-05 Glaxosmithkline Llc CHINOXALIN DERIVATIVES AS PI3 KINASE INHIBITORS
EP2352374B1 (en) * 2008-10-29 2014-09-24 Merck Sharp & Dohme Corp. Novel cyclic benzimidazole derivatives useful anti-diabetic agents
FR2938538B1 (fr) * 2008-11-17 2011-08-05 Univ Nice Sophia Antipolis Procede de preparation d'acides et d'esters boroniques en presence de magnesium metallique
GB0908394D0 (en) 2009-05-15 2009-06-24 Univ Leuven Kath Novel viral replication inhibitors
MX2011013816A (es) 2009-06-29 2012-04-11 Incyte Corp Pirimidinonas como inhibidores de pi3k.
GB0913636D0 (en) 2009-08-05 2009-09-16 Univ Leuven Kath Novel viral replication inhibitors
AR079529A1 (es) * 2009-12-18 2012-02-01 Incyte Corp Derivados arilo y heteroarilo sustituidos y fundidos como inhibidores de la pi3k
US8759359B2 (en) * 2009-12-18 2014-06-24 Incyte Corporation Substituted heteroaryl fused derivatives as PI3K inhibitors
ES2475970T3 (es) * 2009-12-23 2014-07-11 Katholieke Universiteit Leuven Novedosos compuestos antivirales
EP2345643A1 (en) 2009-12-29 2011-07-20 Polichem S.A. New tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof
EP2345641A1 (en) 2009-12-29 2011-07-20 Polichem S.A. New secondary 8-hydroxyquinoline-7-carboxamide derivatives
EP2345642A1 (en) 2009-12-29 2011-07-20 Polichem S.A. Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents
WO2011107530A2 (en) 2010-03-03 2011-09-09 Probiodrug Ag Novel inhibitors
EP2558463A1 (en) 2010-04-14 2013-02-20 Incyte Corporation Fused derivatives as i3 inhibitors
WO2011163195A1 (en) 2010-06-21 2011-12-29 Incyte Corporation Fused pyrrole derivatives as pi3k inhibitors
BR112012033770A2 (pt) 2010-06-30 2016-11-22 Fujifilm Corp novo derivado de nicotinamida ou sal do mesmo
US8633200B2 (en) * 2010-09-08 2014-01-21 Bristol-Myers Squibb Company Inhibitors of human immunodeficiency virus replication
WO2012065963A2 (en) 2010-11-15 2012-05-24 Katholieke Universiteit Leuven Novel antiviral compounds
ES2764848T3 (es) 2010-12-20 2020-06-04 Incyte Holdings Corp N-(1-(fenilo sustituido)etilo)-9H-purina-6-aminas como inhibidores de PI3K
US9108984B2 (en) 2011-03-14 2015-08-18 Incyte Corporation Substituted diamino-pyrimidine and diamino-pyridine derivatives as PI3K inhibitors
US9126948B2 (en) 2011-03-25 2015-09-08 Incyte Holdings Corporation Pyrimidine-4,6-diamine derivatives as PI3K inhibitors
KR20230038593A (ko) 2011-09-02 2023-03-20 인사이트 홀딩스 코포레이션 Pi3k 억제제로서 헤테로시클릴아민
CN104185420B (zh) 2011-11-30 2017-06-09 埃默里大学 用于治疗或预防逆转录病毒和其它病毒感染的抗病毒jak抑制剂
AR090548A1 (es) 2012-04-02 2014-11-19 Incyte Corp Azaheterociclobencilaminas biciclicas como inhibidores de pi3k
SG10201710705UA (en) * 2013-06-21 2018-02-27 Zenith Epigenetics Ltd Novel bicyclic bromodomain inhibitors
WO2015004533A2 (en) 2013-06-21 2015-01-15 Zenith Epigenetics Corp. Novel substituted bicyclic compounds as bromodomain inhibitors
EP3027604B1 (en) 2013-07-31 2019-02-20 Zenith Epigenetics Ltd. Novel quinazolinones as bromodomain inhibitors
CN103554019B (zh) * 2013-09-30 2015-08-05 浙江工业大学 一种甲溴羟喹的合成方法
CN104140402B (zh) * 2014-05-27 2016-01-20 天津市斯芬克司药物研发有限公司 一种苯并噻唑类化合物及其制备方法
US10077277B2 (en) 2014-06-11 2018-09-18 Incyte Corporation Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors
CN104447543B (zh) * 2014-11-10 2016-08-24 苏州康润医药有限公司 3-氨基-7,8-二氟喹啉及其中间体的合成方法
CN104447547B (zh) * 2014-11-10 2017-04-19 苏州康润医药有限公司 4‑氨基异喹啉‑8‑甲酸甲酯的合成方法
HK1245246A1 (zh) 2014-12-01 2018-08-24 恒翼生物医药科技(上海)有限公司 作为溴域抑制剂的取代吡啶酮
JP2017537946A (ja) 2014-12-11 2017-12-21 ゼニス・エピジェネティクス・リミテッドZenith Epigenetics Ltd. ブロモドメイン阻害剤としての置換複素環
CA2966450A1 (en) 2014-12-17 2016-06-23 Olesya KHARENKO Inhibitors of bromodomains
AU2016222556B2 (en) 2015-02-27 2020-08-27 Incyte Holdings Corporation Salts of Pl3K inhibitor and processes for their preparation
WO2016183063A1 (en) 2015-05-11 2016-11-17 Incyte Corporation Crystalline forms of a pi3k inhibitor
WO2016183060A1 (en) 2015-05-11 2016-11-17 Incyte Corporation Process for the synthesis of a phosphoinositide 3-kinase inhibitor
MX2020012826A (es) 2018-06-01 2021-03-09 Incyte Corp Regimen de dosificacion para el tratamiento de trastornos relacionados con fosfatidilinositol 3-cinasas (pi3k).
TWI827677B (zh) 2018-09-18 2024-01-01 美商尼坎醫療公司 作為src同源-2磷酸酶抑制劑之稠合三環衍生物

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH370082A (de) * 1958-12-06 1963-06-30 Geigy Ag J R Verfahren zur Herstellung von neuen N-heterocyclischen Verbindungen
CH385846A (de) 1960-03-31 1964-12-31 Geigy Ag J R Verfahren zur Herstellung von neuen 7-Acyl-8-hydroxy-chinolinen und ihre Verwendung als Fungizide und Bakterizide im Pflanzen- und Materialschutz
JPS5417754B2 (enExample) 1972-12-15 1979-07-02
JPS587637B2 (ja) 1973-12-27 1983-02-10 住友化学工業株式会社 シンキペニシリンノ セイホウ
JPS5227794A (en) * 1975-08-29 1977-03-02 Sumitomo Chem Co Ltd Preparation of synthesis of nnacylaminoo arylacetamido cephalosporin s
JPS5268193A (en) * 1975-11-28 1977-06-06 Sumitomo Chem Co Ltd Synthesis of novel cephalosporin derivatives
JPS5293790A (en) * 1976-02-02 1977-08-06 Sumitomo Chem Co Ltd 7-(n-acylamino-alpha-arylacetamide) cephalosporins
JPH0527385A (ja) * 1991-07-24 1993-02-05 Fuji Photo Film Co Ltd ハロゲン化銀カラー写真感光材料
US5681832A (en) * 1995-02-17 1997-10-28 The United States Of America As Represented By The Department Of Health And Human Services Aroylaniline compounds, pharmaceutical compositions, and methods of using same to inhibit viral activity
WO1998011073A1 (en) * 1996-09-10 1998-03-19 Pharmacia & Upjohn Company 8-hydroxy-7-substituted quinolines as anti-viral agents
FR2761687B1 (fr) 1997-04-08 2000-09-15 Centre Nat Rech Scient Derives de quinoleines, possedant notamment des proprietes antivirales, leurs preparations et leurs applications biologiques
HUP0103460A3 (en) 1998-03-26 2002-11-28 Shionogi & Co Indole derivatives with antiviral activity and pharmaceutical compositions containing them
WO1999062520A1 (en) 1998-06-03 1999-12-09 Merck & Co., Inc. Hiv integrase inhibitors
CA2333771A1 (en) 1998-06-03 1999-12-09 Mark W. Embrey Hiv integrase inhibitors
JP2002516858A (ja) 1998-06-03 2002-06-11 メルク エンド カムパニー インコーポレーテッド Hivインテグラーゼ阻害薬
AU5880600A (en) 1999-06-25 2001-01-31 Merck & Co., Inc. 1-(aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof
US6730682B2 (en) 2000-07-12 2004-05-04 Pharmacia & Upjohn Company Heterocycle carboxamides as antiviral agents
CA2425625A1 (en) 2000-10-12 2002-07-18 Merck & Co., Inc. Aza-and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors
ES2287170T3 (es) * 2000-10-12 2007-12-16 MERCK & CO., INC. Aza- y poliaza-naftalenil-carboxamidas utilies como inhibidores de la vih integrasa.
MXPA03003263A (es) 2000-10-12 2003-06-06 Merck & Co Inc Aza y poliaza naftalenil carboxamidas utiles como inhibidores de la integrasa del virus de inmunodeficiencia humana.
CA2425067A1 (en) 2000-10-12 2002-05-10 Merck & Co., Inc. Aza-and polyaza-naphthalenyl ketones useful as hiv integrase inhibitors

Similar Documents

Publication Publication Date Title
JP2004175807A5 (enExample)
JP2010513322A5 (enExample)
Yeung et al. Inhibitors of HIV-1 attachment. Part 7: indole-7-carboxamides as potent and orally bioavailable antiviral agents
JP2006517220A5 (enExample)
DK3042894T1 (da) Antiviralt middel
NZ590126A (en) Compounds having antiviral properties
JP2010526800A5 (enExample)
JP2018519245A5 (enExample)
JP2018516238A5 (enExample)
JP2016505042A5 (enExample)
JP2011518163A5 (enExample)
JP2004506736A5 (enExample)
JP2004525150A5 (enExample)
EP1829858A3 (en) Dibenzylamine compounds and pharmaceutical use thereof
JP2019514874A5 (enExample)
JP2014514360A5 (enExample)
JP2016536364A5 (enExample)
JP2008510828A5 (enExample)
RU2012129168A (ru) Производные оксазина
JP2011520906A5 (enExample)
JP2010501478A5 (enExample)
WO2016089060A2 (en) Heterocyclic derivatives and use thereof
JP2009535307A5 (enExample)
JP2011519374A5 (enExample)
JP2005535586A5 (enExample)